证券代码：603990 证券简称：麦迪科技 公告编号：2025-087 苏州麦迪斯顿医疗科技股份有限公司 2025年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (五) 公司董事、监事和董事会秘书的出席情况 1、公司在任董事5人，出席5人，其中三人为公司独立董事； 2、公司在任监事3人，出席3人； 3、董事会秘书出席了本次会议；公司其他高级管理人员列席了会议。 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 200 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 69,681,563 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 23.1007 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由董事长陈宁先生主持,会议采用现场投票与网络投票相结合的表 决方式进行表决。本次会议的召集、召开符合《公司法》《公司章程》《公司股东 (一) ...

关于苏州麦迪斯顿医疗科技股份有限公司 2025 年第三次临时股东大会的 法律意见书 二〇二五年十二月 北京市中伦（上海）律师事务所 北京市中伦（上海）律师事务所 法律意见书 法律意见书 关于苏州麦迪斯顿医疗科技股份有限公司 2025 年第三次临时股东大会的 法律意见书 致：苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"） 北京市中伦（上海）律师事务所（以下简称"本所"）接受公司的委托，指 派律师出席并见证公司2025年第三次临时股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 （以下简称"《股东会规则》"）、《律师事务所从事证券法律业务管理办法》 （以下简称"《证券法律业务管理办法》"）、《律师事务所证券法律业务执业 规则（试行）》（以下简称"《证券法律业务执业规则》"）等相关法律、行政 法规、规章、规范性文件及《苏州麦迪斯顿医疗科技股份有限公司章程》（以下 简称"《公司章程》"）的规定，就本次会议的召集与召开程序、召集人资格、 出席会议人员资格、会议表决程序及表决结果等事宜，出 ...

苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）第四届董事会第 四十次会议于 2025 年 12 月 29 日在苏州工业园区归家巷 222 号麦迪科技公司 10 楼会议室以现场表决的方式召开。本次董事会会议通知于 2025 年 12 月 26 日以 邮件形式发出。会议由陈宁先生主持，会议应出席董事 5 名，实际出席董事 5 名，公司高级管理人员列席了本次会议。会议召集及召开方式符合《中华人民共 和国公司法》（以下简称"《公司法》"）和《公司章程》等有关规定，所形成的决 议合法有效。 二、董事会会议审议情况 （一）审议并通过了《关于调整董事会专门委员会委员的议案》； 为保证公司董事会专门委员会能够顺利有序高效的开展工作，根据《公司法》 等有关法律法规及《公司章程》《董事会薪酬与考核委员会工作细则》《董事会审 计委员会工作细则》的相关规定，董事会同意选举任小军先生为公司第四届董事 会薪酬与考核委员会主任委员、第四届董事会审计委员会委员，任期自董事会审 议通过之日起至本届董事会任期届满。 表决结果：同意 5 票；反对 0 票；弃权 0 票。 苏州麦迪斯顿医疗科技股份有限公司 第四届董事会第四十次会议决议公告 本 ...

Company Overview - MediTech (SH 603990) announced its fourth board meeting on December 29, 2025, held in Suzhou, where it reviewed proposals including adjustments to the board's specialized committee members [1] Financial Performance - For the year 2024, MediTech's revenue composition is as follows: Software and Information Technology Services account for 49.97%, the Photovoltaic industry for 36.18%, Medical Services for 13.27%, and Other businesses for 0.58% [1] Market Position - As of the report, MediTech has a market capitalization of 4.7 billion yuan [1]

Group 1 - The core viewpoint of the article highlights the launch of the Youmai Companion Robot V1.0 by Madi Technology in collaboration with UBTECH Robotics, focusing on addressing the core pain points of the elderly, including loneliness, health, and safety [1] - The Youmai Companion Robot features AI voice chat, medication reminders, remote appliance control, millimeter-wave vital sign monitoring, and emergency alerts, with a price point of 50,000 yuan [1] - The product has already undergone testing in social welfare institutions and rehabilitation hospitals, with the initial batch of 100 units sold out during the launch event [1] Group 2 - Madi Technology's founder, Weng Kang, announced a new strategy centered on data elements, with AI healthcare and AI robotics as key focuses, aiming to create a "New Madi" in the AI era [2] - The company has made significant progress in building a trusted data space for healthcare and recently won a bid for an 18 million yuan project related to an intelligent platform [2] - Madi Technology is collaborating with partners such as Zhejiang Second Hospital and Jinglian Technology to explore the deep integration of medical AI and data elements [2]

Core Viewpoint - The stock of Madi Technology has experienced fluctuations, with a notable decline of 5.19% on December 29, 2023, despite a year-to-date increase of 50.97% [1] Group 1: Stock Performance - As of December 29, 2023, Madi Technology's stock price is 15.52 yuan per share, with a market capitalization of 4.754 billion yuan [1] - The stock has seen a net outflow of 1.3398 million yuan in principal funds, with significant buying and selling activity from large orders [1] - Over the past five trading days, the stock has decreased by 1.96%, and over the past 20 days, it has decreased by 0.70%, while it has increased by 6.30% over the past 60 days [1] Group 2: Company Overview - Madi Technology, established on August 14, 2009, and listed on December 8, 2016, specializes in clinical medical management information systems (CIS) and overall solutions for clinical informationization [2] - The company's revenue composition includes self-developed software (40.39%), operation and maintenance services (31.55%), medical services (21.12%), overall solutions (4.60%), purchased software and hardware (1.95%), and others (0.40%) [2] - As of September 30, 2023, the number of shareholders has increased by 7.17% to 38,900, with an average of 7,864 circulating shares per person, a decrease of 6.69% [2] Group 3: Financial Performance - For the period from January to September 2023, Madi Technology reported a revenue of 223 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, reflecting a year-on-year increase of 120.49% [2] - The company has distributed a total of 71.36 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]

12月25日，麦迪科技大宗交易成交65万股，成交额1005.55万元，占当日总成交额的2.42%，成交价 15.47元，较市场收盘价16.28元折价4.98%。 ...

Market Performance - The software development sector increased by 0.77% on December 25, with Guangdao Tui leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] Stock Highlights - Guangdao Tui (code: 920680) saw a significant rise of 29.55%, closing at 1.71, with a trading volume of 244,800 shares and a transaction value of 37.48 million yuan [1] - Shengbang Security (code: 688651) increased by 11.67%, closing at 45.82, with a transaction value of 314 million yuan [1] - Zhizhen Technology (code: 003007) rose by 10.01%, closing at 39.01, with a transaction value of 197 million yuan [1] - Sifang Jingchuang (code: 300468) increased by 6.63%, closing at 36.33, with a transaction value of 3.304 billion yuan [1] Capital Flow - The software development sector experienced a net outflow of 153 million yuan from institutional investors and 141 million yuan from retail investors, while retail investors had a net inflow of 294 million yuan [2] - Notable stocks with significant capital flow include Sifang Jingchuang, which had a net inflow of 320 million yuan from institutional investors [3] Individual Stock Performance - Zhizhen Technology had a net inflow of 99.19 million yuan from institutional investors, representing 50.35% of its total capital flow [3] - Jingbeifang experienced a net inflow of 72.57 million yuan from institutional investors, accounting for 10.82% of its total capital flow [3] - Other stocks like Tonghuashun and Zhinanzhen saw net outflows from both institutional and retail investors, indicating mixed investor sentiment [3]

一、 公司募集资金现金管理到期赎回情况 公司于 2025 年 11 月 18 日向浙商银行苏州分行营业部办理了银行结构性存 款业务。截至本公告披露日，公司已将上述产品赎回，收回本金共 7,000 万元， 获得理财收益 10.25 万元。 上述产品具体情况如下： 证券代码：603990 证券简称：麦迪科技 公告编号：2025-086 苏州麦迪斯顿医疗科技股份有限公司 关于使用部分闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第四届董事会第三十一次会议、第四届监事会第十五次会议，审议通 过了《关于使用部分闲置募集资金进行现金管理的议案》，同意公司在确保不影 响募集资金投资项目进度和募集资金安全的前提下，对暂时闲置的部分募集资金 不超过人民币 2 亿元（包含本数）进行现金管理，余额在上述额度内，资金可以 滚动使用，用于购买单笔期限最长不超过 12 个月（含 12 个月）的结构性存款等 安全性高的保本型产品， ...

Core Viewpoint - The upcoming product launch of the Xiaomai Kangyang Companion Robot V1.0, which integrates Alibaba's Tongyi Qianwen MAX model, highlights advancements in AI companion technology with rich expressive capabilities [1] Group 1 - The Xiaomai Kangyang Companion Robot V1.0 is set to be unveiled at an upcoming event [1] - The product features integration with Alibaba's advanced AI model, enhancing its functionality [1] - The robot is designed to have a variety of expressions, indicating a focus on user interaction and emotional engagement [1]